SWI/SNF-complex-deficient malignancies can be determined by immunohistochemical staining with INI1 antibody for SMARCB1-deficient and BRG1 antibody for SMARCA4-deficient carcinomas. This evidence concerns the gene SMARCB1 and carcinoma.